Abstract
Background/Aims: The roles of inflammatory and fibrogenic biomarkers in chronic hepatitis B (CHB) infection and hepatitis B virüs (HBV)-related cirrhosis remain incompletely understood. The current study investigated the diagnostic and discriminative ability of amphiregulin (AREG), interleukin-6 (IL-6), and neuropilin-1 (Nrp-1) as biomarkers of HBV-related cirrhosis.
Materials and Methods: This cross-sectional analytical study included 70 patients with CHB (43 without cirrhosis and 27 with HBVrelated cirrhosis) and 60 healthy controls. Clinical and laboratory data were obtained from hospital records. Serum IL-6, Nrp-1, and AREG levels collected during outpatient visits were measured using enzyme-linked immunosorbent assay. Group differences were analyzed using the Kruskal–Wallis test, discriminative performance was evaluated using receiver operating characteristic (ROC) analysis, and factors independently associated with cirrhosis were identified using logistic regression.
Results: IL-6 and Nrp-1 levels were higher in patients with noncirrhotic and HBV-related cirrhotic CHB than in healthy controls (P < .001), with no significant difference between the patient subgroups. AREG levels were lower in the overall CHB cohort than in controls (P < .001) but higher in patients with cirrhosis than in those without cirrhosis (P = .001). ROC analysis showed that AREG had moderate discriminative ability for HBV-related cirrhosis (area under the curve (AUC) = 0.749). The optimal Youden-derived cutoff value was 2.29 ng/mL, with a sensitivity of 74% and a specificity of 65%. In logistic regression, AREG was independently associated with HBV-related cirrhosis (P = .012). Addition of ln-transformed AREG to age- and sex-adjusted aspartate aminotransferase-to-platelet ratio index (APRI)- and Fibrosis-4 index (FIB-4)-based models increased the AUC from 0.923 to 0.970 and from 0.938 to 0.980, respectively.
Conclusion: AREG may serve as a complementary biomarker with moderate discriminative value for HBV-related cirrhosis but is unlikely to be useful as a standalone diagnostic or prognostic marker. Although IL-6 and Nrp-1 reflected underlying inflammatory activity, their ability to distinguish cirrhosis was limited.
Cite this article as: Karakoc Ozudogru F, Karaca B, Turker N, et al. Discriminative role of interleukin-6, neuropilin-1, and amphiregulin for cirrhosis in patients with chronic hepatitis B infection. Turk J Gastroenterol. 2026;37(9):985-994.
Most read articles by the same author(s)
- Nilay Danis, Imre Altuglu, Ayse Arslan, Abdullah Murat Buyruk, Fulya Günsar, Aysin Zeytinoglu, Ulus Salih Akarca, The under water part of the iceberg: Anti-HCV positivity , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)
- Fulya GÜNŞAR, Yaman TOKAT, Funda YILMAZ, Zeki KARASU, Murat ALKANAT, Ahmet MEMİŞ, Cengiz ÇAVUŞOĞLU, Disseminated tuberculosis with massive gastrointestinal bleeding after liver transplantation , Turkish Journal of Gastroenterology: Vol. 11 No. 4 (2000): Turkish Journal of Gastroenterology
- Necla OSMANOĞLU, Fulya GÜNŞAR, Ulus Salih AKARCA, Gül YÜCE, Chronic interahepatic cholestatsis due to sarcoidosis , Turkish Journal of Gastroenterology: Vol. 9 No. 3 (1998): Turkish Journal of Gastroenterology
- Dinç Dinçer, Fulya Günşar, From the Editor , Turkish Journal of Gastroenterology: Vol. 29 No. 1 (2018): Turkish Journal of Gastroenterology
- Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, İlhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Sami Kınıklı, Faruk Karakeçili, Gökmen Zararsız, Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience , Turkish Journal of Gastroenterology: Vol. 31 No. 4 (2020): Turkish Journal of Gastroenterology
- İmre ALTUĞLU, Rüçhan SERTÖZ, Ayşegül AKSOY, Derya GÜRSEL, Uğur TÜZÜNER, Fulya GÜNŞAR, Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey , Turkish Journal of Gastroenterology: Vol. 24 No. 4 (2013): Turkish Journal of Gastroenterology
- Sezgin Vatansever, Rasim Farajov, Hüseyin Cahit Yılmaz, Murat Zeytunlu, Zehra Betül Paköz, Murat Kılıç, Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria , Turkish Journal of Gastroenterology: Vol. 30 No. 1 (2019): Turkish Journal of Gastroenterology
- Kevser ONBAŞI, Fulya GÜNŞAR, Aytül Z. SİN, Ömür ARDENİZ, Ali KOKULUDAĞ, Filiz SEBİK, Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis , Turkish Journal of Gastroenterology: Vol. 16 No. 2 (2005): Turkish Journal of Gastroenterology
- Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, A A, Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience , Turkish Journal of Gastroenterology: Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)

This work is licensed under a Creative Commons Attribution 4.0 International License.